Characteristics Free-Living Healthy senior subjects   Hypercholesterolemic subjects
    NS-7 capsule NS-6 capsule NS-7 capsule NS-6 capsule
    Baseline Baseline Baseline Baseline
1 Subjects
  Males (n) 20 24 32 20
  Females (n) 10 15 9 10
Total (males + females) n = 30 39 41 30
2 Age (years)
  Males 66.20 ± 1.58* 64.46 ± 1.13* 61.84 ± 1.60* 62.25 ± 1.76*
  Females 59.40 ± 2.48 59.60 ± 1.30 61.22 ± 2.62 53.80 ± 1.87
  Total (males + females) 63.93 ± 7.89 62.59 ± 0.93 61.71 ± 1.35 59.43 ± 1.50
3 Body weight (kg)
  Males 78.85 ± 1.33 81.54 ± 0.60 77.41 ± 0.79 75.90 ± 1.30
  Females 72.90 ± 3.44 62.27 ± 1.25 73.56 ± 2.10 65.60 ± 0.75
  Total (males + females) 76.73 ± 1.52 74.13 ± 1.63 76.56 ± 0.80 72.47 ± 1.27
4 Body mass index (kg/m2)
  Males 25.44 ± 0.25 25.87 ± 0.16 25.12 ± 0.29 24.85 ± 0.38
  Females 25.86 ± 0.53 24.66 ± 0.45 25.81 ± 0.33 26.85 ± 0.34
  Total (males + females) 25.58 ± 0.24 25.40 ± 0.22 25.27 ± 0.24 25.18 ± 0.29
5 Initial cholesterol (mmol/L)
  Males 4.13 ± 0.17 4.42 ± 0.13 6.08 ± 0.08 6.01 ± 0.08
  Females 4.67 ± 0.19 4.39 ± 0.14 5.97 ± 0.16 6.10 ± 0.16
Total (males + females) 4.31 ± 0.14 4.41± 0.10 6.06 ± 0.07 6.04 ± 0.08
6 Intial triglycerides (mmo/L)    
  Males 1.37 ± 0.12 1.48 ± 0.04 2.63 ± 0.31 2.48 ± 0.20
  Females 1.76 ± 0.20 1.59 ± 0.21 2.34 ± 0.68 2.17 ± 0.35
  Total (males + females) 1.50 ± 0.11 1.52 ± 0.10 2.56 ± 0.28 3.37 ± 0.18
1The baseline and treatments profiles for subjects completing all phases were reported in this Table.
*Data expressed as means ± SE (Standard Error)
Table 4: Characteristics of the study populations of healthy senior and hypercholesterolemic human subjects1.